nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprost Tromethamine—GALR3—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0408	0.0616	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0317	0.0478	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0286	0.0431	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Gilles de la Tourette syndrome	0.0221	0.0333	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—nervous system—Gilles de la Tourette syndrome	0.022	0.0652	CbGeAlD
Dinoprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0214	0.0322	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—central nervous system—Gilles de la Tourette syndrome	0.0212	0.0628	CbGeAlD
Dinoprost Tromethamine—PTGIR—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0209	0.0315	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0209	0.0315	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—midbrain—Gilles de la Tourette syndrome	0.0203	0.0601	CbGeAlD
Dinoprost Tromethamine—PTGER3—nervous system—Gilles de la Tourette syndrome	0.0193	0.0572	CbGeAlD
Dinoprost Tromethamine—TBXA2R—brain—Gilles de la Tourette syndrome	0.0191	0.0568	CbGeAlD
Dinoprost Tromethamine—PTGER3—central nervous system—Gilles de la Tourette syndrome	0.0186	0.0551	CbGeAlD
Dinoprost Tromethamine—HPGDS—nervous system—Gilles de la Tourette syndrome	0.0167	0.0494	CbGeAlD
Dinoprost Tromethamine—HPGDS—central nervous system—Gilles de la Tourette syndrome	0.016	0.0476	CbGeAlD
Dinoprost Tromethamine—PTGER3—brain—Gilles de la Tourette syndrome	0.0147	0.0437	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—midbrain—Gilles de la Tourette syndrome	0.0146	0.0433	CbGeAlD
Dinoprost Tromethamine—PTGIR—nervous system—Gilles de la Tourette syndrome	0.0136	0.0403	CbGeAlD
Dinoprost Tromethamine—PTGIR—central nervous system—Gilles de la Tourette syndrome	0.0131	0.0388	CbGeAlD
Dinoprost Tromethamine—HPGDS—brain—Gilles de la Tourette syndrome	0.0127	0.0378	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—nervous system—Gilles de la Tourette syndrome	0.012	0.0356	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—nervous system—Gilles de la Tourette syndrome	0.0119	0.0352	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—central nervous system—Gilles de la Tourette syndrome	0.0115	0.0342	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—central nervous system—Gilles de la Tourette syndrome	0.0114	0.0339	CbGeAlD
Dinoprost Tromethamine—SLC22A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—Gilles de la Tourette syndrome	0.011	0.0167	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—brain—Gilles de la Tourette syndrome	0.0104	0.0308	CbGeAlD
Dinoprost Tromethamine—SLC22A7—brain—Gilles de la Tourette syndrome	0.00988	0.0293	CbGeAlD
Dinoprost Tromethamine—SLC22A6—brain—Gilles de la Tourette syndrome	0.00954	0.0283	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—brain—Gilles de la Tourette syndrome	0.00917	0.0272	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—brain—Gilles de la Tourette syndrome	0.00908	0.0269	CbGeAlD
Dinoprost Tromethamine—PTGFR—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00809	0.0122	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00786	0.0118	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Amine compound SLC transporters—SLC6A3—Gilles de la Tourette syndrome	0.00766	0.0116	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—nervous system—Gilles de la Tourette syndrome	0.00747	0.0222	CbGeAlD
Dinoprost Tromethamine—GALR3—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00724	0.0109	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—central nervous system—Gilles de la Tourette syndrome	0.00719	0.0213	CbGeAlD
Dinoprost Tromethamine—GALR3—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00703	0.0106	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00672	0.0101	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00655	0.00988	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00653	0.00984	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00608	0.00917	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00576	0.00869	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—brain—Gilles de la Tourette syndrome	0.00571	0.0169	CbGeAlD
Dinoprost Tromethamine—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00565	0.00852	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00559	0.00843	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00521	0.00786	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00521	0.00786	CbGpPWpGaD
Dinoprost Tromethamine—SLCO2A1—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00515	0.00777	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00513	0.00773	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00512	0.00773	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00507	0.00764	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00506	0.00763	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00492	0.00742	CbGpPWpGaD
Dinoprost Tromethamine—SLCO3A1—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00488	0.00737	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00471	0.00711	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.0047	0.00709	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00458	0.00691	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00456	0.00688	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00447	0.00674	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00439	0.00662	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00433	0.00654	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00431	0.0065	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00427	0.00644	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00426	0.00642	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00426	0.00642	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00425	0.00641	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00404	0.00609	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00403	0.00608	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00397	0.00598	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00391	0.0059	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00382	0.00576	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00365	0.0055	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00364	0.00549	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00359	0.00542	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—HDC—Gilles de la Tourette syndrome	0.00358	0.00539	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00352	0.0053	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00344	0.00519	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00344	0.00519	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00341	0.00515	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.0034	0.00513	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00334	0.00504	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00334	0.00504	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.0033	0.00498	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.0033	0.00498	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00318	0.0048	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00311	0.00469	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00311	0.00469	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00308	0.00464	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00307	0.00463	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00301	0.00454	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.003	0.00452	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00298	0.00449	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00298	0.00449	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00295	0.00445	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00295	0.00445	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00292	0.00441	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00288	0.00435	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00286	0.00432	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00286	0.00432	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00283	0.00427	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00282	0.00425	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00278	0.00419	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00277	0.00418	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00272	0.00411	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00267	0.00402	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00267	0.00402	CbGpPWpGaD
Dinoprost Tromethamine—SLCO2A1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00262	0.00395	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00258	0.00389	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A11—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00257	0.00387	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00255	0.00385	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00252	0.0038	CbGpPWpGaD
Dinoprost Tromethamine—SLCO3A1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00248	0.00374	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00248	0.00374	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00241	0.00363	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00233	0.00351	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00229	0.00346	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00225	0.00339	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00224	0.00339	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00224	0.00339	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00224	0.00338	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00223	0.00336	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00223	0.00336	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00218	0.0033	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00218	0.00329	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00218	0.00329	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00218	0.00329	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00218	0.00329	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00215	0.00325	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00207	0.00313	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00204	0.00307	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00203	0.00306	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00203	0.00306	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00196	0.00295	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00194	0.00293	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00192	0.0029	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00191	0.00288	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00187	0.00282	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00187	0.00282	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00187	0.00281	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00174	0.00263	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00174	0.00262	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00173	0.00261	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00169	0.00256	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00168	0.00254	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00168	0.00253	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00163	0.00246	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00158	0.00238	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00157	0.00237	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00157	0.00237	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00157	0.00236	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00153	0.00231	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00145	0.00219	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00143	0.00215	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00142	0.00215	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00142	0.00215	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00142	0.00215	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00136	0.00205	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00133	0.00201	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A11—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.0013	0.00197	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.0013	0.00196	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00129	0.00195	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00129	0.00194	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00127	0.00191	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00127	0.00191	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00126	0.0019	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00123	0.00186	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00123	0.00186	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00122	0.00184	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.0012	0.00181	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00118	0.00178	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00118	0.00178	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00117	0.00177	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00115	0.00174	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00115	0.00174	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00115	0.00173	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00115	0.00173	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00114	0.00172	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00112	0.00169	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00112	0.00169	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00111	0.00167	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.0011	0.00166	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00106	0.00161	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00104	0.00157	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00104	0.00157	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00103	0.00156	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.001	0.00151	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000997	0.0015	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000994	0.0015	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000932	0.00141	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—HDC—Gilles de la Tourette syndrome	0.000931	0.0014	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00093	0.0014	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000903	0.00136	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000842	0.00127	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000841	0.00127	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00083	0.00125	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000821	0.00124	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000804	0.00121	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000804	0.00121	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000745	0.00112	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00073	0.0011	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00073	0.0011	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000695	0.00105	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000692	0.00104	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000681	0.00103	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000681	0.00103	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000675	0.00102	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000661	0.000997	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000661	0.000997	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000653	0.000985	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000629	0.000949	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000615	0.000928	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000615	0.000928	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000589	0.000888	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00044	0.000664	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000431	0.00065	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000431	0.00065	CbGpPWpGaD
